Tumor registry at LSUHSC earns top NCI quality honor

November 29, 2012

New Orleans, LA - The Surveillance Epidemiology and End Results (SEER) Program of the National Institutes of Health's National Cancer Institute awarded the Louisiana Tumor Registry at the LSU Health Sciences Center New Orleans School of Public Health with a 2012 Data Quality Profile First Place Award. LSUHSC's Louisiana Tumor Registry is the only SEER expansion registry to receive a first place award. This is the fourth time LSUHSC's Louisiana Tumor Registry has earned this award, and the third consecutive year. The SEER Program is the most authoritative source of information on cancer incidence and survival in the United States.

The SEER Program evaluates the quality of data from each registry every year. Sixteen measures are evaluated, including the estimate completeness of cases (for computing incidence rate), percent unknown or missing for key demographic and tumor variables, and follow-up rates (for calculating survival).

"This honor not only recognizes the commitment to high quality of Dr. Vivien Chen, who led the Louisiana Tumor Registry until very recently, and the staff here at the LSUHSC School of Public Health, but the dedicated efforts of the staffs of the regional registries and hospital registries throughout the state with whom we collaborate," notes Dr. Xiao-Cheng Wu, Associate Professor and Director of the Louisiana Tumor Registry at LSU Health Sciences Center New Orleans School of Public Health.

The primary function of a cancer registry is to record the occurrence of cancer in a population. Information collected includes demographics, tumor characteristics, stage of disease at diagnosis, treatment, and survival. Information on risk factors is usually not available from the reporting sources. However, data from the registry often provides clues to be pursued in special research studies conducted by qualified scientists with external funding.

The SEER Program collects cancer incidence and survival data from 18 population-based cancer registries in the United States. It is considered to be the standard for quality among cancer registries around the world. Quality control has been an integral part of SEER since its inception.

Cancer is a reportable disease in the State of Louisiana. Hospitals, private pathology laboratories, radiation centers and health care providers who diagnose or treat cancer are required by law to report the cancer cases to the Louisiana Tumor Registry which was transferred from the Louisiana Office of Public Health to LSU Health Sciences Center New Orleans in 1995. The Registry includes the central office located at the LSU Health Sciences Center New Orleans School of Public Health and eight regional offices - Regions I and III at LSU Health Sciences Center in New Orleans; Region II at Mary Bird Perkins Cancer Center in Baton Rouge; Region IV at Acadiana Medical Research Foundation in Lafayette; Region V at Christus St. Patrick Hospital of Lake Charles; and Regions VI, VII and VIII at the University of Louisiana at Monroe. Each regional registry is responsible for ascertaining all cancer cases from all possible sources in its region. The central office consolidates, processes, edits, compiles, and analyzes the data as well as ensures complete, timely and high quality data.
-end-
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's academic health leader, LSUHSC comprises a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSUHSC faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSUHSC research enterprise generates jobs and enormous economic impact. LSUHSC faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu and http://www.twitter.com/LSUHSCHealth.

Louisiana State University Health Sciences Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.